# Clover Health Investments, Corp.: financial statements, quarterly

CLOV · Nasdaq · CIK 1801170 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clov.md) · [Financials](/companies/clov/financials.md) · [Filings](/companies/clov/filings.md) · [Insiders](/companies/clov/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clov/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [306](/filings/0001801170-24-000234.md) | [312 d](/filings/0001801170-26-000057.md) | [347](/filings/0001801170-25-000132.md) | [356](/filings/0001801170-25-000204.md) | [331](/filings/0001801170-25-000275.md) | [337 d](/filings/0001801170-26-000057.md) | [462](/filings/0001801170-26-000122.md) | [478](/filings/0001801170-26-000200.md) | [497](/filings/0001801170-25-000275.md) | [488 d](/filings/0001801170-26-000057.md) | [749](/filings/0001801170-26-000122.md) | [743](/filings/0001801170-26-000200.md) |
| Gross profit | $m | [70.2](/filings/0001801170-24-000234.md) | [64.0 d](/filings/0001801170-24-000064.md) | [81.8](/filings/0001801170-24-000102.md) | [108](/filings/0001801170-24-000165.md) | [81.2](/filings/0001801170-24-000234.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(33.6)](/filings/0001801170-24-000234.md) | [(63.1) d](/filings/0001801170-26-000057.md) | [(22.7)](/filings/0001801170-25-000132.md) | [7.2](/filings/0001801170-25-000204.md) | [(8.8)](/filings/0001801170-25-000275.md) | [(21.4) d](/filings/0001801170-26-000057.md) | [(1.3)](/filings/0001801170-26-000122.md) | [(10.6)](/filings/0001801170-26-000200.md) | [(24.4)](/filings/0001801170-25-000275.md) | [(49.3) d](/filings/0001801170-26-000057.md) | [27.3](/filings/0001801170-26-000122.md) | [28.0](/filings/0001801170-26-000200.md) |
| Interest expense | $m | [0.0](/filings/0001801170-23-000104.md) | [0.0 d](/filings/0001801170-24-000064.md) | not reported | [0.0](/filings/0001801170-24-000165.md) | [0.0](/filings/0001801170-24-000234.md) | [0.0 d](/filings/0001801170-26-000057.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(41.5)](/filings/0001801170-24-000234.md) | [(70.5) d](/filings/0001801170-26-000057.md) | [(19.2)](/filings/0001801170-25-000275.md) | [7.4](/filings/0001801170-25-000275.md) | [(9.2)](/filings/0001801170-25-000275.md) | [(22.1) d](/filings/0001801170-26-000057.md) | [(1.3)](/filings/0001801170-26-000200.md) | [(10.6)](/filings/0001801170-26-000200.md) | [(24.4)](/filings/0001801170-25-000275.md) | [(49.3) d](/filings/0001801170-26-000057.md) | [27.3](/filings/0001801170-26-000200.md) | [28.0](/filings/0001801170-26-000200.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001801170-23-000104.md) | not reported | not reported | not reported | not reported | not reported | [0.00](/filings/0001801170-26-000122.md) | [(0.02)](/filings/0001801170-26-000200.md) | not reported | not reported | [0.05](/filings/0001801170-26-000122.md) | [0.05](/filings/0001801170-26-000200.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001801170-23-000104.md) | not reported | not reported | not reported | not reported | not reported | [0.00](/filings/0001801170-26-000122.md) | [(0.02)](/filings/0001801170-26-000200.md) | not reported | not reported | [0.05](/filings/0001801170-26-000122.md) | [0.05](/filings/0001801170-26-000200.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [299](/filings/0001801170-24-000234.md) | [123](/filings/0001801170-26-000057.md) | [208](/filings/0001801170-24-000102.md) | [255](/filings/0001801170-24-000165.md) | [288](/filings/0001801170-24-000234.md) | [195](/filings/0001801170-26-000057.md) | not reported | not reported | not reported | [78.3](/filings/0001801170-26-000057.md) | not reported | not reported |
| Current assets | $m | [916](/filings/0001801170-23-000104.md) | [428](/filings/0001801170-25-000052.md) | [553](/filings/0001801170-24-000102.md) | [550](/filings/0001801170-24-000165.md) | [433](/filings/0001801170-24-000234.md) | [343](/filings/0001801170-26-000057.md) | [331](/filings/0001801170-25-000132.md) | [363](/filings/0001801170-25-000204.md) | [331](/filings/0001801170-25-000275.md) | [308](/filings/0001801170-26-000200.md) | [448](/filings/0001801170-26-000122.md) | [485](/filings/0001801170-26-000200.md) |
| Total assets | $m | [685](/filings/0001801170-24-000234.md) | [571](/filings/0001801170-25-000052.md) | [672](/filings/0001801170-24-000102.md) | [674](/filings/0001801170-24-000165.md) | [653](/filings/0001801170-24-000234.md) | [581](/filings/0001801170-26-000057.md) | [584](/filings/0001801170-25-000132.md) | [575](/filings/0001801170-25-000204.md) | [560](/filings/0001801170-25-000275.md) | [541](/filings/0001801170-26-000200.md) | [698](/filings/0001801170-26-000122.md) | [720](/filings/0001801170-26-000200.md) |
| Current liabilities | $m | [719](/filings/0001801170-23-000104.md) | [261](/filings/0001801170-25-000052.md) | [356](/filings/0001801170-24-000102.md) | [325](/filings/0001801170-24-000165.md) | [280](/filings/0001801170-24-000234.md) | [214](/filings/0001801170-26-000057.md) | [216](/filings/0001801170-25-000132.md) | [202](/filings/0001801170-25-000204.md) | [193](/filings/0001801170-25-000275.md) | [209](/filings/0001801170-26-000200.md) | [337](/filings/0001801170-26-000122.md) | [323](/filings/0001801170-26-000200.md) |
| Total liabilities | $m | [738](/filings/0001801170-23-000104.md) | [284](/filings/0001801170-25-000052.md) | [379](/filings/0001801170-24-000102.md) | [349](/filings/0001801170-24-000165.md) | [311](/filings/0001801170-24-000234.md) | [240](/filings/0001801170-26-000057.md) | [248](/filings/0001801170-25-000132.md) | [231](/filings/0001801170-25-000204.md) | [219](/filings/0001801170-25-000275.md) | [232](/filings/0001801170-26-000200.md) | [358](/filings/0001801170-26-000122.md) | [344](/filings/0001801170-26-000200.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [322](/filings/0001801170-24-000234.md) | [286](/filings/0001801170-26-000057.md) | [292](/filings/0001801170-25-000275.md) | [325](/filings/0001801170-25-000275.md) | [342](/filings/0001801170-25-000275.md) | [341](/filings/0001801170-26-000200.md) | [336](/filings/0001801170-26-000200.md) | [344](/filings/0001801170-26-000200.md) | [341](/filings/0001801170-25-000275.md) | [309](/filings/0001801170-26-000200.md) | [339](/filings/0001801170-26-000200.md) | [376](/filings/0001801170-26-000200.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(18.8) d](/filings/0001801170-24-000234.md) | [(258) d](/filings/0001801170-26-000057.md) | [25.9](/filings/0001801170-25-000132.md) | [44.8 d](/filings/0001801170-25-000204.md) | [50.0 d](/filings/0001801170-25-000275.md) | [(85.8) d](/filings/0001801170-26-000057.md) | [(16.3)](/filings/0001801170-26-000122.md) | [5.4 d](/filings/0001801170-26-000200.md) | [12.1 d](/filings/0001801170-25-000275.md) | [(68.2) d](/filings/0001801170-26-000057.md) | [108](/filings/0001801170-26-000122.md) | [25.2 d](/filings/0001801170-26-000200.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001801170-24-000234.md) | [(0.3) d](/filings/0001801170-26-000057.md) | [0.4](/filings/0001801170-25-000132.md) | [0.4 d](/filings/0001801170-25-000204.md) | [0.4 d](/filings/0001801170-25-000275.md) | [0.3 d](/filings/0001801170-26-000057.md) | [0.2](/filings/0001801170-26-000122.md) | [0.6 d](/filings/0001801170-26-000200.md) | [0.7 d](/filings/0001801170-25-000275.md) | [0.6 d](/filings/0001801170-26-000057.md) | [0.9](/filings/0001801170-26-000122.md) | [0.7 d](/filings/0001801170-26-000200.md) |
| Share repurchases | $m | [0.0 d](/filings/0001801170-24-000234.md) | [0.0 d](/filings/0001801170-26-000057.md) | [0.0](/filings/0001801170-25-000132.md) | [1.8 d](/filings/0001801170-25-000204.md) | [0.0 d](/filings/0001801170-25-000275.md) | [0.0 d](/filings/0001801170-26-000057.md) | [18.3](/filings/0001801170-26-000122.md) | [0.0 d](/filings/0001801170-26-000200.md) | [0.0 d](/filings/0001801170-25-000275.md) | [0.0 d](/filings/0001801170-26-000057.md) | [0.0](/filings/0001801170-26-000122.md) | [0.0 d](/filings/0001801170-26-000200.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [478](/filings/0001801170-23-000104.md) | [479](/filings/0001801170-24-000102.md) | [479](/filings/0001801170-24-000165.md) | [481](/filings/0001801170-24-000234.md) | [486](/filings/0001801170-25-000132.md) | [495](/filings/0001801170-25-000204.md) | [490](/filings/0001801170-25-000275.md) | [497](/filings/0001801170-26-000122.md) | [509](/filings/0001801170-26-000200.md) | [513](/filings/0001801170-25-000275.md) | [533](/filings/0001801170-26-000122.md) | [545](/filings/0001801170-26-000200.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.